Abstract: This invention pertains to methods for treating infections caused by human papillomaviruses. It has been determined that immunization with HPV16 and HPV 18 virus like particles provides cross-protection against other HPV types.
Type:
Grant
Filed:
December 16, 2005
Date of Patent:
December 28, 2010
Assignee:
GlaxoSmithKline Biologicals, s.a.
Inventors:
Gary Dubin, Bruce Innis, Moncef Mohammed Slaoui, Martine Anne Cecile Wettendorff